ARTICLE | Clinical News
CenTNF: A 73-patient Phase II study
August 1, 1994 7:00 AM UTC
Centocor Inc. (CNTO), Malvern, Penn. Product: CenTNF monoclonal antibody Indication: Rheumatoid arthritis Status: A 73-patient Phase II study is completed and data will be presented in October at the...